June 2015

 

In this Supplement

Surgical Bypass Summit

Individualizing Surgical Bypass: Changing the Paradigm

Sponsored by Gore & Associates

Issue

Supplement

Supplement

Download a PDF of this supplement

INTRODUCTION

Surgical Bypass Summit

By Russell H. Samson, MD, FACS, RVT

SESSION 1

Current state of bypass for lower extremity revascularization: What are the real results?

Role of Surgical Bypass in a Limb Preservation Program

By Richard F. Neville, MD

Alternative Conduits

By Efthymios D. Avgerinos, MD, PhD

Vein Versus Heparin-Bonded ePTFE

By Prof. Raffaele Pulli; Walter Dorigo, MD; and Prof. Carlo Pratesi, on behalf of the Italian Registry Group*

SESSION 2

Bypass in the world of "endovascular first": How does it fit in today's treatment algorithm?

There Are Negative Consequences That Persist After Failed Endovascular Treatment of CLI

By Ross Milner, MD

Gender Differences in PAD Treatment

By Venita Chandra, MD

SESSION 3

What are the advantages of a prosthetic conduit?

Should Complications and Modes of Failure Affect Our Choice?

By R. Clement Darling, III, MD

CBAS® Heparin Surface

By Russell H. Samson, MD, FACS, RVT

SESSION 4

Future improvements in graft performance

The Impact of Drug Therapy on Surgical Bypass

By Russell H. Samson, MD, FACS, RVT

Sequential Bypass

By Jean Bismuth, MD

SESSION 5

How will financial considerations affect future decisions?

Open Surgery Versus Endovascular Revascularization

By Michael Stoner, MD

Prevalence of Amputation

By Alejandro Fabiani, MD
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.